ArticleNature biotechnology2023
High-throughput, targeted MHC class I immunopeptidomics using a functional genetics screening platform.
Peter M Bruno et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
33 papers cite it
this papercites it